Plain-English translation of NCT07824102 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is investigating how two hormones — luteinizing hormone (LH) and human chorionic gonadotropin (hCG) — may affect several health conditions including osteoporosis, thyroid disease, and adrenal problems. While these hormones have long been studied for their role in reproduction, researchers now believe they may have important effects on bone health, weight, and how the body uses calcium and thyroid hormones. This study will help doctors better understand why certain endocrine disorders become more common as people age.
Many health problems become more common during and after menopause, but doctors don't fully understand all the reasons why. This study exists because researchers have noticed that some bone loss and weight gain happen when LH levels rise, even before estrogen drops significantly. By studying these hormones more carefully, doctors hope to find better ways to prevent and treat bone disease, thyroid problems, and other endocrine conditions without relying solely on hormone replacement therapy, which carries certain risks.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be evaluated as part of five different patient groups depending on your condition: those with osteoporosis, high calcium levels or parathyroid disease, thyroid illness, adrenal disease, or pituitary disease. Researchers will collect blood samples and review your medical information to measure your hormone levels and understand how they relate to your specific condition. The study is enrolling up to 20,000 participants and is currently recruiting, so your involvement would contribute to a large, long-term research effort.
AI-generated summary from trial data · Sep 18, 2026 · Not medical advice
Denmark